SBI Securities’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
SBI Securities's BMY Position: Q2 2026 in Review
SBI Securities reduced its Bristol-Myers Squibb (BMY) stake by 2.4% in Q2 2026, selling an estimated $30.8K and leaving 22,094 shares worth $1.27M. The position accounts for 0.03% of the portfolio, ranked #250.
SBI Securities first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.37M in Q1 2026. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- SBI Securities held 22,094 shares of Bristol-Myers Squibb worth $1.27M as of Q2 2026.
- SBI Securities sold 536 Bristol-Myers Squibb shares in Q2 2026, an estimated $30.8K.
- Bristol-Myers Squibb made up 0.03% of SBI Securities's portfolio in Q2 2026, its #250 holding.
- SBI Securities first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
- SBI Securities's Bristol-Myers Squibb position peaked at $1.37M in Q1 2026.
- 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.